The 95th-bound Red Line trains were briefly delayed Wednesday afternoon at the Chicago Avenue stop after a 58-year-old man was attacked and his head was cut, according to police and CTA officials.

The transit agency announced Wednesday the station entrance in the Thompson Center, now under construction to become Google's ...

The North Riverside Park Mall debuted a makeover Wednesday, just before the holiday rush. The Feil Organization, which bought ...

A young Chicago girl is spreading love through her art on World Kindness Day, using her creativity to convey kindness to friends, neighbors and strangers alike. Olivia Bosse has been coloring and ...

Terence Flynn, an analyst from Morgan Stanley, reiterated the Buy rating on AbbVie (ABBV – Research Report). The associated price target ...

AbbVie said a recently acquired drug candidate for schizophrenia missed the key goal in mid-stage studies, pushing its stock ...

AbbVie Inc. shares fell the most in three years after two mid-stage trials of its drug to treat schizophrenia failed to meet ...

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Shares of AbbVie have dropped sharply ...

Analyst Carter Gould of Barclays maintained a Buy rating on AbbVie (ABBV – Research Report), retaining the price target of $212.00.

AbbVie, in announcing the Cerevel deal late last year, said it believed emraclidine had the potential to transform the schizophrenia treatment landscape and represented a multibillion-dollar peak ...

AbbVie said its recently acquired emraclidine drug candidate for schizophrenia missed the key goal in a pair of mid-stage studies, sending the biopharmaceutical company's shares down more than 10% in ...